Try

QUEST DIAGNOSTICS INC

DGXUnited States

83 filed reports · 510 financial concepts · 2 earnings calls · 5 media appearances

Filed reports

83 reports · Mar 2016 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 70 operating metrics, 392 guidance figures.

Report typeReportsFactsPeriods
Current · 8-KSEC EDGAR41351Jun 2016 to Jun 2026
Quarterly · 10-QSEC EDGAR325,442Mar 2016 to Jun 2026
Annual · 10-KSEC EDGAR106,203Dec 2016 to Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Jul 23, 2026358Open
FY2026 Q28-KJun 30, 2026Jul 23, 20265Open
FY2026 Q110-QMar 31, 2026Apr 22, 2026230Open
FY2026 Q18-KMar 31, 2026Apr 21, 20268Open
FY202510-KDec 31, 2025Feb 26, 20261,165Open
FY2025 Q48-KDec 31, 2025Feb 10, 20269Open
FY2025 Q48-KDec 31, 2025Jan 12, 20262Open
FY2025 Q38-KSep 30, 2025Oct 21, 20254Open
FY2025 Q310-QSep 30, 2025Oct 21, 2025255Open
FY2025 Q210-QJun 30, 2025Jul 23, 2025157Open
FY2025 Q28-KJun 30, 2025Jul 22, 20258Open
FY2025 Q110-QMar 31, 2025Apr 23, 2025148Open

Financial data

510 concepts · 11,996 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial486 concepts · 10,673 facts · Dec 2014 to Jul 2026

  • Cash and cash equivalents at carrying value59 · Dec 2014 to Jun 2026
  • Dividends payable current and noncurrent59 · Dec 2014 to Jun 2026
  • Stockholders equity including portion attributable to noncontrolling interest59 · Dec 2014 to Jun 2026
  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value58 · Dec 2014 to Jun 2026
  • Amortization of intangible assets58 · Dec 2014 to Jun 2026
  • Capital expenditures incurred but not yet paid58 · Dec 2014 to Jun 2026
  • Comprehensive income net of tax58 · Dec 2014 to Jun 2026
  • Comprehensive income net of tax including portion attributable to noncontrolling interest58 · Dec 2014 to Jun 2026
  • Cost of revenue (US GAAP)58 · Dec 2014 to Jun 2026
  • Costs and expenses58 · Dec 2014 to Jun 2026
  • Deferred income tax expense benefit58 · Dec 2014 to Jun 2026
  • Depreciation58 · Dec 2014 to Jun 2026
  • Depreciation depletion and amortization58 · Dec 2014 to Jun 2026
  • Dividends common stock cash58 · Dec 2014 to Jun 2026
  • Income loss from equity method investments58 · Dec 2014 to Jun 2026
  • Income taxes paid58 · Dec 2014 to Jun 2026
  • Income tax expense benefit58 · Dec 2014 to Jun 2026
  • Increase decrease in accounts payable and accrued liabilities58 · Dec 2014 to Jun 2026
  • Increase decrease in accounts receivable58 · Dec 2014 to Jun 2026
  • Increase decrease in accrued income taxes payable58 · Dec 2014 to Jun 2026
  • Increase decrease in other operating capital net58 · Dec 2014 to Jun 2026
  • Incremental common shares attributable to share based payment arrangements58 · Dec 2014 to Jun 2026
  • Interest income expense net58 · Dec 2014 to Jun 2026
  • Minority interest decrease from distributions to noncontrolling interest holders58 · Dec 2014 to Jun 2026

Segment10 concepts · 761 facts · Dec 2014 to Jun 2026

  • Percentage of net revenues325 · Dec 2016 to Jun 2026
  • Operating income loss174 · Dec 2014 to Jun 2026
  • Revenue116 · Dec 2014 to Jun 2026
  • Depreciation depletion and amortization66 · Dec 2014 to Jun 2026
  • Payments to acquire property plant and equipment27 · Dec 2014 to Dec 2022
  • Routine clinical testing services20 · Dec 2021 to Dec 2025
  • Segment expenditure addition to long lived assets15 · Dec 2021 to Dec 2025
  • Segment reporting other item amount14 · Dec 2022 to Jun 2026
  • Percentage of net revenues from Diagnostic Information Services business3 · Dec 2016 to Dec 2018
  • Gain loss on sale of business1 · Sep 2015

Guidance9 concepts · 349 facts · Jul 2016 to Jul 2026

  • Capital Expenditures Guidance85 · Jul 2016 to Jul 2026
  • Revenue Guidance79 · Jul 2016 to Jul 2026
  • EPS (Diluted) Guidance75 · Jul 2016 to Jul 2026
  • Revenue Growth Guidance64 · Oct 2016 to Jul 2026
  • EPS (Diluted) Guidance (Adjusted (non-GAAP))32 · Oct 2016 to Feb 2024
  • Revenue Growth Guidance (Comparable)8 · Oct 2016 to Jul 2017
  • EPS (Diluted) Guidance (excluding amortization; Adjusted (non-GAAP))2 · Apr 2018
  • Operating Margin Guidance2 · Jan 2026
  • Revenue Growth Guidance (Adjusted (non-GAAP))2 · Feb 2018

Product3 concepts · 168 facts · Dec 2014 to Dec 2025

  • Revenue99 · Dec 2014 to Sep 2022
  • Routine clinical testing services65 · Dec 2020 to Dec 2025
  • Percentage of net revenues4 · Dec 2022 to Dec 2025

KPI1 concepts · 44 facts · Jun 2016 to Jun 2026

  • Average Selling Price per Unit YoY Change44 · Jun 2016 to Jun 2026

Geography1 concepts · 1 facts · Dec 2024

  • Canada1 · Dec 2024

Segments

930 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments4 members · 475 facts

  • Diagnostic Information Services Business228 · Dec 2014 to Jun 2026
  • All Other Segments152 · Dec 2014 to Jun 2026
  • Corporate94 · Dec 2014 to Jun 2026
  • Clinical Trials1 · Sep 2015

Subsegments6 members · 286 facts

  • Healthcare Insurers127 · Dec 2016 to Jun 2026
  • Client Payers39 · Dec 2016 to Jun 2026
  • DS Businesses39 · Dec 2016 to Jun 2026
  • Government Payers39 · Dec 2016 to Jun 2026
  • Patients22 · Jun 2019 to Jun 2026
  • Patient20 · Dec 2016 to Dec 2025

Product or servicesrt:ProductOrServiceAxis7 members · 148 facts

  • Allotherservices28 · Dec 2017 to Dec 2025
  • Anatomicpathologytestingservices28 · Dec 2017 to Dec 2025
  • Genebasedandesoterictestingservices28 · Dec 2017 to Dec 2025
  • Routine Clinical Testing And Other Services28 · Dec 2017 to Dec 2025
  • COVID19 Testing Services27 · Dec 2018 to Dec 2025
  • DS Revenues5 · Dec 2021 to Dec 2025
  • Medicare And Medicaid Programs4 · Dec 2022 to Dec 2025

Product or serviceus-gaap:ProductOrServiceAxis4 members · 20 facts

  • Allotherservices5 · Dec 2014 to Dec 2018
  • Anatomicpathologytestingservices5 · Dec 2014 to Dec 2018
  • Genebasedandesoterictestingservices5 · Dec 2014 to Dec 2018
  • Routine Clinical Testing And Other Services5 · Dec 2014 to Dec 2018

Statement geographical1 member · 1 facts

  • CA1 · Dec 2024

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary86 claims from 9 reports · Sep 2024 to Jun 2026
  • Management discussion (MD&A) commentary70 claims from 4 reports · Sep 2024 to Jun 2026
  • Risk-factor changes8 claims from 1 reports · Dec 2025
  • Risk factors52 risks from 2 annual reports · 2024 to 2025

Earnings calls

2 calls · Apr 2026 to Jul 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Jul 23, 2026
  • FY2026 Q1Apr 21, 2026

Executive media

5 appearances

Podcasts, interviews and conference appearances by the company's executives, with their claims.

  • TV interviews4 · May 2020 to Feb 2026
  • Other appearances1 · May 2026

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

QUEST DIAGNOSTICS INC (DGX) data · FactIQ